• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

连续注射贝伐单抗联合激光光凝治疗视网膜动脉大动脉瘤相关黄斑水肿

Serial bevacizumab injections and laser photocoagulation for macular edema associated with a retinal artery macroaneurysm.

作者信息

Leung Ella H, Reddy Ashvini K, Vedula Anil S, Flynn Harry W

机构信息

Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami, Miami, FL, USA.

Department of Ophthalmology, University of Virginia, Charlottesville, VA, USA.

出版信息

Clin Ophthalmol. 2015 Apr 4;9:601-9. doi: 10.2147/OPTH.S80504. eCollection 2015.

DOI:10.2147/OPTH.S80504
PMID:25897199
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4396452/
Abstract

An 84-year-old female with a history of hypertension and dyslipidemia was referred for a retinal artery macroaneurysm with exudation that had extended into the macula. She underwent a total of six injections of bevacizumab, with some improvement in visual acuity and retinal thickness. Due to persistent macular edema, focal laser photocoagulation was performed around the macroaneurysm. The vision remained at 20/30 during 20 months of follow up. Although anti-vascular endothelial growth factor therapy may improve vision and decrease retinal thickness in retinal artery macroaneurysm, recalcitrant cases may be treated with laser photocoagulation to seal the leaking vessel.

摘要

一位84岁女性,有高血压和血脂异常病史,因视网膜动脉大动脉瘤伴渗出并累及黄斑而前来就诊。她总共接受了6次贝伐单抗注射,视力和视网膜厚度有一定改善。由于黄斑水肿持续存在,在大动脉瘤周围进行了局部激光光凝治疗。在20个月的随访期间,视力维持在20/30。尽管抗血管内皮生长因子治疗可能改善视网膜动脉大动脉瘤患者的视力并降低视网膜厚度,但对于顽固病例,可采用激光光凝治疗来封闭渗漏血管。

相似文献

1
Serial bevacizumab injections and laser photocoagulation for macular edema associated with a retinal artery macroaneurysm.连续注射贝伐单抗联合激光光凝治疗视网膜动脉大动脉瘤相关黄斑水肿
Clin Ophthalmol. 2015 Apr 4;9:601-9. doi: 10.2147/OPTH.S80504. eCollection 2015.
2
Combined treatment with intravitreal bevacizumab and laser photocoagulation for exudative maculopathy in facioscapulohumeral muscular dystrophy.玻璃体内注射贝伐单抗联合激光光凝治疗面肩肱型肌营养不良症的渗出性黄斑病变。
Ophthalmic Genet. 2017 Sep-Oct;38(5):490-493. doi: 10.1080/13816810.2017.1279183. Epub 2017 Jan 25.
3
Retinal Macroaneurysm Associated with Congenital Anomalous Retinal Artery.
Optom Vis Sci. 2017 Jul;94(7):781-785. doi: 10.1097/OPX.0000000000001095.
4
Bevacizumab versus bevacizumab and macular grid photocoagulation for macular edema in eyes with non-ischemic branch retinal vein occlusion: results from a prospective randomized study.贝伐单抗对比贝伐单抗联合黄斑格栅光凝治疗非缺血性视网膜分支静脉阻塞性黄斑水肿:一项前瞻性随机研究的结果
Graefes Arch Clin Exp Ophthalmol. 2019 May;257(5):913-920. doi: 10.1007/s00417-018-04223-9. Epub 2019 Jan 4.
5
Intravitreal Anti-Vascular Endothelial Growth Factor for Macular Edema due to Complex Retinal Arterial Macroaneurysms.玻璃体内注射抗血管内皮生长因子治疗复杂性视网膜动脉大动脉瘤所致黄斑水肿
Case Rep Ophthalmol. 2017 Mar 7;8(1):137-143. doi: 10.1159/000458517. eCollection 2017 Jan-Apr.
6
Efficacy of single bevacizumab injection as adjuvant therapy to laser photocoagulation in macular edema secondary to branch retinal vein occlusion.单次注射贝伐单抗作为激光光凝术辅助治疗视网膜分支静脉阻塞继发黄斑水肿的疗效
Clin Ophthalmol. 2016 Oct 31;10:2135-2140. doi: 10.2147/OPTH.S116745. eCollection 2016.
7
Long-term follow-up of intravitreal bevacizumab in retinal arterial macroaneurysm: a case report.玻璃体内注射贝伐单抗治疗视网膜动脉大动脉瘤的长期随访:病例报告
Case Rep Ophthalmol. 2011 Sep;2(3):387-91. doi: 10.1159/000334788. Epub 2011 Dec 13.
8
Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema.玻璃体内注射贝伐单抗(阿瓦斯汀)治疗持续性弥漫性糖尿病性黄斑水肿。
Retina. 2006 Nov-Dec;26(9):999-1005. doi: 10.1097/01.iae.0000247165.38655.bf.
9
Combination therapy with intravitreal bevacizumab and macular grid and scatter laser photocoagulation in patients with macular edema secondary to branch retinal vein occlusion.玻璃体腔注射贝伐单抗联合黄斑格栅与多点散射激光光凝治疗视网膜分支静脉阻塞继发黄斑水肿患者
J Ocul Pharmacol Ther. 2015 Apr;31(3):179-85. doi: 10.1089/jop.2014.0069. Epub 2015 Feb 25.
10
Anti-vascular endothelial growth factor for macular oedema secondary to branch retinal vein occlusion.抗血管内皮生长因子治疗视网膜分支静脉阻塞继发的黄斑水肿。
Cochrane Database Syst Rev. 2013 Jan 31(1):CD009510. doi: 10.1002/14651858.CD009510.pub2.

引用本文的文献

1
Retinal laser photocoagulation and intravitreal injection of anti-VEGF for hemorrhagic retinal arterial microaneurysm.视网膜激光光凝术联合玻璃体内注射抗血管内皮生长因子(VEGF)治疗出血性视网膜动脉微动脉瘤
Int J Ophthalmol. 2023 Dec 18;16(12):2041-2048. doi: 10.18240/ijo.2023.12.17. eCollection 2023.
2
Triple retinal arterial macroaneurysms in a hypertensive patient with hypothyroidism.高血压伴甲状腺功能减退症患者的三重视网膜动脉巨大动脉瘤。
BMC Ophthalmol. 2023 May 10;23(1):207. doi: 10.1186/s12886-023-02953-x.
3
Influence of bevacizumab therapy and intraretinal hemorrhage in long-term outcomes of hemorrhagic retinal arterial macroaneurysm.

本文引用的文献

1
Laser therapy versus observation for symptomatic retinal artery macroaneurysms.有症状视网膜动脉大动脉瘤的激光治疗与观察对比
Graefes Arch Clin Exp Ophthalmol. 2015 Apr;253(4):537-41. doi: 10.1007/s00417-014-2730-3. Epub 2014 Jul 13.
2
Intravitreal anti-VEGF therapy for retinal macroaneurysm.玻璃体内抗血管内皮生长因子疗法治疗视网膜大动脉瘤
Klin Monbl Augenheilkd. 2013 Apr;230(4):392-5. doi: 10.1055/s-0032-1328377. Epub 2013 Apr 29.
3
Intravitreal bevacizumab for symptomatic retinal arterial macroaneurysm.玻璃体内注射贝伐单抗治疗症状性视网膜动脉大动脉瘤。
贝伐单抗治疗和视网膜内出血对出血性视网膜动脉大动脉瘤长期结局的影响。
Sci Rep. 2021 Jul 9;11(1):14246. doi: 10.1038/s41598-021-93811-7.
4
To treat or not to treat: a clinical series of retinal arterial macroaneurysms: A single-center retrospective study.治疗还是不治疗:视网膜动脉大动脉瘤的临床系列病例:一项单中心回顾性研究。
Medicine (Baltimore). 2020 Jan;99(5):e19077. doi: 10.1097/MD.0000000000019077.
5
Retinal Arterial Macroaneurysms: Updating your Memory on RAM Management.视网膜动脉大动脉瘤:更新你对视网膜动脉大动脉瘤管理的认识
Curr Ophthalmol Rep. 2019 Jun;7(2):73-79. doi: 10.1007/s40135-019-00202-3. Epub 2019 Apr 16.
6
Intravitreal Anti-Vascular Endothelial Growth Factor for Macular Edema due to Complex Retinal Arterial Macroaneurysms.玻璃体内注射抗血管内皮生长因子治疗复杂性视网膜动脉大动脉瘤所致黄斑水肿
Case Rep Ophthalmol. 2017 Mar 7;8(1):137-143. doi: 10.1159/000458517. eCollection 2017 Jan-Apr.
Am J Ophthalmol. 2013 May;155(5):898-904. doi: 10.1016/j.ajo.2012.12.003. Epub 2013 Feb 4.
4
Idiopathic juxtafoveal retinal telangiectasis and retinal macroaneurysm treated with indocyanine green dye-enhanced photocoagulation.特发性近黄斑部视网膜微血管瘤和视网膜大动脉瘤经吲哚菁绿染料增强光凝治疗。
Panminerva Med. 2012 Dec;54(1 Suppl 4):93-6.
5
Intravitreal bevacizumab for macular complications from retinal arterial macroaneurysms.玻璃体内注射贝伐单抗治疗视网膜动脉大动脉瘤引起的黄斑并发症。
Am J Ophthalmol. 2013 Feb;155(2):287-294.e1. doi: 10.1016/j.ajo.2012.07.029. Epub 2012 Oct 27.
6
Long-term follow-up of intravitreal bevacizumab in retinal arterial macroaneurysm: a case report.玻璃体内注射贝伐单抗治疗视网膜动脉大动脉瘤的长期随访:病例报告
Case Rep Ophthalmol. 2011 Sep;2(3):387-91. doi: 10.1159/000334788. Epub 2011 Dec 13.
7
The use of bevacizumab in a multilevel retinal hemorrhage secondary to retinal macroaneurysm: a 39-month follow-up case report.贝伐单抗用于视网膜大动脉瘤继发的多级视网膜出血:一份39个月的随访病例报告。
Clin Ophthalmol. 2011;5:1475-7. doi: 10.2147/OPTH.S23535. Epub 2011 Oct 12.
8
Intravitreous VEGF-A in eyes with massive vitreous hemorrhage.玻璃体内血管内皮生长因子 A 与大量玻璃体出血。
Graefes Arch Clin Exp Ophthalmol. 2011 Dec;249(12):1805-10. doi: 10.1007/s00417-011-1795-5. Epub 2011 Aug 19.
9
Management of ruptured retinal arterial macroaneurysm with intravitreal bevacizumab.玻璃体内注射贝伐单抗治疗视网膜动脉大动脉瘤破裂
Ophthalmic Surg Lasers Imaging. 2010 Jul-Aug;41(4):1-5.
10
Genetic repression of mouse VEGF expression regulates coagulation cascade.基因抑制小鼠 VEGF 表达调控凝血级联反应。
IUBMB Life. 2010 Nov;62(11):819-24. doi: 10.1002/iub.389.